- Home
- NXTC vs SKK Comparison
NXTC vs SKK Comparison
Compare NXTC & SKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXTC
- SKK
- Stock Information
- Founded
- NXTC 2015
- SKK 2013
- Country
- NXTC United States
- SKK Singapore
- Employees
- NXTC N/A
- SKK N/A
- Industry
- NXTC Biotechnology: Pharmaceutical Preparations
- SKK
- Sector
- NXTC Health Care
- SKK
- Exchange
- NXTC Nasdaq
- SKK NYSE
- Market Cap
- NXTC 13.9M
- SKK 11.6M
- IPO Year
- NXTC 2019
- SKK 2024
- Fundamental
- Price
- NXTC $0.48
- SKK $0.65
- Analyst Decision
- NXTC Strong Buy
- SKK
- Analyst Count
- NXTC 2
- SKK 0
- Target Price
- NXTC $3.50
- SKK N/A
- AVG Volume (30 Days)
- NXTC 336.1K
- SKK 121.6K
- Earning Date
- NXTC 07-31-2025
- SKK 02-14-2025
- Dividend Yield
- NXTC N/A
- SKK N/A
- EPS Growth
- NXTC N/A
- SKK 99.13
- EPS
- NXTC N/A
- SKK 0.03
- Revenue
- NXTC N/A
- SKK $11,301,000.00
- Revenue This Year
- NXTC N/A
- SKK N/A
- Revenue Next Year
- NXTC N/A
- SKK N/A
- P/E Ratio
- NXTC N/A
- SKK $24.63
- Revenue Growth
- NXTC N/A
- SKK 15.80
- 52 Week Low
- NXTC $0.22
- SKK $0.53
- 52 Week High
- NXTC $1.82
- SKK $11.45
- Technical
- Relative Strength Index (RSI)
- NXTC 44.82
- SKK N/A
- Support Level
- NXTC $0.45
- SKK N/A
- Resistance Level
- NXTC $0.51
- SKK N/A
- Average True Range (ATR)
- NXTC 0.07
- SKK 0.00
- MACD
- NXTC -0.01
- SKK 0.00
- Stochastic Oscillator
- NXTC 3.24
- SKK 0.00
About NXTC NextCure Inc.
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.
About SKK SKK HOLDINGS LIMITED
SKK Holdings Ltd is a civil engineering service provider that specializes in subsurface utility works in Singapore. It construct and maintain various public works and infrastructure projects that serve the society and the environment. Its projects are the subsurface work related to projects undertaken by the Public Utilities Board (PUB) and Singapore Telecommunications Limited. The nature of these projects is related to repairing of pumping mains, sewer maintenance and pipe cable laying.